Presentation is loading. Please wait.

Presentation is loading. Please wait.

From: Pharmacokinetic Analysis of Melphalan after Superselective Ophthalmic Artery Infusion in Preclinical Models and Retinoblastoma Patients Invest. Ophthalmol.

Similar presentations


Presentation on theme: "From: Pharmacokinetic Analysis of Melphalan after Superselective Ophthalmic Artery Infusion in Preclinical Models and Retinoblastoma Patients Invest. Ophthalmol."— Presentation transcript:

1 From: Pharmacokinetic Analysis of Melphalan after Superselective Ophthalmic Artery Infusion in Preclinical Models and Retinoblastoma Patients Invest. Ophthalmol. Vis. Sci ;53(7): doi: /iovs Figure Legend: Dose-dependent cytotoxicty of melphalan in (A) Y79 and (B) WERI-RB retinoblastoma cell lines. Data are presented as mean ± SEM of duplicate experiments done in triplicates. The insets show the effect of topotecan 10 nM on melphalan cytotoxicty of both cell lines. Date of download: 10/29/2017 The Association for Research in Vision and Ophthalmology Copyright © All rights reserved.


Download ppt "From: Pharmacokinetic Analysis of Melphalan after Superselective Ophthalmic Artery Infusion in Preclinical Models and Retinoblastoma Patients Invest. Ophthalmol."

Similar presentations


Ads by Google